Curanex Pharmaceuticals Inc SEC filings CURX
Curanex Pharmaceuticals Inc has 65 filings in SEC EDGAR's recent list, going back to Jun 20, 2024. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 19, 2026 | — |
| S-8 | Employee stock plan registration | Jul 21, 2026 | — |
| 424B4 | Prospectus | Aug 26, 2025 | — |
| 424B4 | Prospectus | Aug 26, 2025 | — |
| FWP | Free writing prospectus | Jul 22, 2025 | — |
| S-1/A | Amended registration statement | Jul 18, 2025 | — |
| FWP | Free writing prospectus | Jul 10, 2025 | — |
| S-1/A | Amended registration statement | Jul 1, 2025 | — |
| FWP | Free writing prospectus | Mar 19, 2025 | — |
| S-1/A | Amended registration statement | Mar 17, 2025 | — |
| S-1/A | Amended registration statement | Feb 14, 2025 | — |
| S-1/A | Amended registration statement | Nov 27, 2024 | — |
| S-1/A | Amended registration statement | Nov 1, 2024 | — |
| S-1 | Registration statement | Oct 16, 2024 | — |
Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CURX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Jericho, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2025942
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.